What is the projected market valuation for the Agriculture Biological Control Agents Market in 2035?

The projected market valuation for the Agriculture Biological Control Agents Market in 2035 is 20.7 USD Billion. Read More

What was the market valuation for the Agriculture Biological Control Agents Market in 2024?

The market valuation for the Agriculture Biological Control Agents Market in 2024 was 7.813 USD Billion. Read More

What is the expected CAGR for the Agriculture Biological Control Agents Market during the forecast period 2025 - 2035?

The expected CAGR for the Agriculture Biological Control Agents Market during the forecast period 2025 - 2035 is 9.26%. Read More

Which company is a key player in the Agriculture Biological Control Agents Market?

Key players in the Agriculture Biological Control Agents Market include BASF SE, Syngenta AG, and Bayer AG. Read More

What segment of the Agriculture Biological Control Agents Market had the highest valuation in 2024?

In 2024, the segment of Bioinsecticides had a valuation of 1.8 USD Billion. Read More

What is the projected valuation for the Soil Application segment by 2035?

The projected valuation for the Soil Application segment by 2035 is 6.5 USD Billion. Read More

How does the valuation of Natural Predators compare to that of Bioinsecticides in 2024?

In 2024, the valuation of Natural Predators was 1.2 USD Billion, which is lower than the 1.8 USD Billion valuation of Bioinsecticides. Read More

What is the expected market size for Foliar Application by 2035?

The expected market size for Foliar Application by 2035 is 8.0 USD Billion. Read More

Which crop type is projected to have a valuation of 5.7 USD Billion by 2035?

The Fruit and Vegetable Crops segment is projected to have a valuation of 5.7 USD Billion by 2035. Read More

What formulation type is expected to reach a valuation of 7.5 USD Billion by 2035?

Granular Formulations are expected to reach a valuation of 7.5 USD Billion by 2035. Read More

Agriculture Biological Control Agents Market

ID: MRFR/Agri/29802-HCR

128 Pages

Snehal Singh

Last Updated: April 06, 2026

Agriculture Biological Control Agents Market Size, Share, Industry Trend & Analysis Research Report By Agent Type (Microbial Control Agents, Natural Predators, Bioinsecticides, Biopesticides, Entomopathogenic Nematodes), By Application Method (Soil Application, Foliar Application, Seed Treatment), By Crop Type (Field Crops, Horticultural Crops, Ornamental Plants, Fruit and Vegetable Crops), By Functionality (Pest Control, Disease Control, Weed Control), By Formulation Type (Liquid Formulations, Granular Formulations, Powder Formulations) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

Agriculture Biological Control Agents Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Pharmaceutical, BY Agent Type (USD Billion)
4.1.1 Microbial Control Agents
4.1.2 Natural Predators
4.1.3 Bioinsecticides
4.1.4 Biopesticides
4.1.5 Entomopathogenic Nematodes
4.2 Pharmaceutical, BY Application Method (USD Billion)
4.2.1 Soil Application
4.2.2 Foliar Application
4.2.3 Seed Treatment
4.3 Pharmaceutical, BY Crop Type (USD Billion)
4.3.1 Field Crops
4.3.2 Horticultural Crops
4.3.3 Ornamental Plants
4.3.4 Fruit and Vegetable Crops
4.4 Pharmaceutical, BY Functionality (USD Billion)
4.4.1 Pest Control
4.4.2 Disease Control
4.4.3 Weed Control
4.5 Pharmaceutical, BY Formulation Type (USD Billion)
4.5.1 Liquid Formulations
4.5.2 Granular Formulations
4.5.3 Powder Formulations
4.6 Pharmaceutical, BY Region (USD Billion)
4.6.1 North America
4.6.1.1 US
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 UK
4.6.2.3 France
4.6.2.4 Russia
4.6.2.5 Italy
4.6.2.6 Spain
4.6.2.7 Rest of Europe
4.6.3 APAC
4.6.3.1 China
4.6.3.2 India
4.6.3.3 Japan
4.6.3.4 South Korea
4.6.3.5 Malaysia
4.6.3.6 Thailand
4.6.3.7 Indonesia
4.6.3.8 Rest of APAC
4.6.4 South America
4.6.4.1 Brazil
4.6.4.2 Mexico
4.6.4.3 Argentina
4.6.4.4 Rest of South America
4.6.5 MEA
4.6.5.1 GCC Countries
4.6.5.2 South Africa
4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Pharmaceutical
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 BASF SE (DE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Syngenta AG (CH)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Bayer AG (DE)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Corteva Agriscience (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 FMC Corporation (US)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 Valent BioSciences LLC (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Certis USA LLC (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Koppert Biological Systems (NL)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Biobest Group NV (BE)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY AGENT TYPE
6.4 US MARKET ANALYSIS BY APPLICATION METHOD
6.5 US MARKET ANALYSIS BY CROP TYPE
6.6 US MARKET ANALYSIS BY FUNCTIONALITY
6.7 US MARKET ANALYSIS BY FORMULATION TYPE
6.8 CANADA MARKET ANALYSIS BY AGENT TYPE
6.9 CANADA MARKET ANALYSIS BY APPLICATION METHOD
6.10 CANADA MARKET ANALYSIS BY CROP TYPE
6.11 CANADA MARKET ANALYSIS BY FUNCTIONALITY
6.12 CANADA MARKET ANALYSIS BY FORMULATION TYPE
6.13 EUROPE MARKET ANALYSIS
6.14 GERMANY MARKET ANALYSIS BY AGENT TYPE
6.15 GERMANY MARKET ANALYSIS BY APPLICATION METHOD
6.16 GERMANY MARKET ANALYSIS BY CROP TYPE
6.17 GERMANY MARKET ANALYSIS BY FUNCTIONALITY
6.18 GERMANY MARKET ANALYSIS BY FORMULATION TYPE
6.19 UK MARKET ANALYSIS BY AGENT TYPE
6.20 UK MARKET ANALYSIS BY APPLICATION METHOD
6.21 UK MARKET ANALYSIS BY CROP TYPE
6.22 UK MARKET ANALYSIS BY FUNCTIONALITY
6.23 UK MARKET ANALYSIS BY FORMULATION TYPE
6.24 FRANCE MARKET ANALYSIS BY AGENT TYPE
6.25 FRANCE MARKET ANALYSIS BY APPLICATION METHOD
6.26 FRANCE MARKET ANALYSIS BY CROP TYPE
6.27 FRANCE MARKET ANALYSIS BY FUNCTIONALITY
6.28 FRANCE MARKET ANALYSIS BY FORMULATION TYPE
6.29 RUSSIA MARKET ANALYSIS BY AGENT TYPE
6.30 RUSSIA MARKET ANALYSIS BY APPLICATION METHOD
6.31 RUSSIA MARKET ANALYSIS BY CROP TYPE
6.32 RUSSIA MARKET ANALYSIS BY FUNCTIONALITY
6.33 RUSSIA MARKET ANALYSIS BY FORMULATION TYPE
6.34 ITALY MARKET ANALYSIS BY AGENT TYPE
6.35 ITALY MARKET ANALYSIS BY APPLICATION METHOD
6.36 ITALY MARKET ANALYSIS BY CROP TYPE
6.37 ITALY MARKET ANALYSIS BY FUNCTIONALITY
6.38 ITALY MARKET ANALYSIS BY FORMULATION TYPE
6.39 SPAIN MARKET ANALYSIS BY AGENT TYPE
6.40 SPAIN MARKET ANALYSIS BY APPLICATION METHOD
6.41 SPAIN MARKET ANALYSIS BY CROP TYPE
6.42 SPAIN MARKET ANALYSIS BY FUNCTIONALITY
6.43 SPAIN MARKET ANALYSIS BY FORMULATION TYPE
6.44 REST OF EUROPE MARKET ANALYSIS BY AGENT TYPE
6.45 REST OF EUROPE MARKET ANALYSIS BY APPLICATION METHOD
6.46 REST OF EUROPE MARKET ANALYSIS BY CROP TYPE
6.47 REST OF EUROPE MARKET ANALYSIS BY FUNCTIONALITY
6.48 REST OF EUROPE MARKET ANALYSIS BY FORMULATION TYPE
6.49 APAC MARKET ANALYSIS
6.50 CHINA MARKET ANALYSIS BY AGENT TYPE
6.51 CHINA MARKET ANALYSIS BY APPLICATION METHOD
6.52 CHINA MARKET ANALYSIS BY CROP TYPE
6.53 CHINA MARKET ANALYSIS BY FUNCTIONALITY
6.54 CHINA MARKET ANALYSIS BY FORMULATION TYPE
6.55 INDIA MARKET ANALYSIS BY AGENT TYPE
6.56 INDIA MARKET ANALYSIS BY APPLICATION METHOD
6.57 INDIA MARKET ANALYSIS BY CROP TYPE
6.58 INDIA MARKET ANALYSIS BY FUNCTIONALITY
6.59 INDIA MARKET ANALYSIS BY FORMULATION TYPE
6.60 JAPAN MARKET ANALYSIS BY AGENT TYPE
6.61 JAPAN MARKET ANALYSIS BY APPLICATION METHOD
6.62 JAPAN MARKET ANALYSIS BY CROP TYPE
6.63 JAPAN MARKET ANALYSIS BY FUNCTIONALITY
6.64 JAPAN MARKET ANALYSIS BY FORMULATION TYPE
6.65 SOUTH KOREA MARKET ANALYSIS BY AGENT TYPE
6.66 SOUTH KOREA MARKET ANALYSIS BY APPLICATION METHOD
6.67 SOUTH KOREA MARKET ANALYSIS BY CROP TYPE
6.68 SOUTH KOREA MARKET ANALYSIS BY FUNCTIONALITY
6.69 SOUTH KOREA MARKET ANALYSIS BY FORMULATION TYPE
6.70 MALAYSIA MARKET ANALYSIS BY AGENT TYPE
6.71 MALAYSIA MARKET ANALYSIS BY APPLICATION METHOD
6.72 MALAYSIA MARKET ANALYSIS BY CROP TYPE
6.73 MALAYSIA MARKET ANALYSIS BY FUNCTIONALITY
6.74 MALAYSIA MARKET ANALYSIS BY FORMULATION TYPE
6.75 THAILAND MARKET ANALYSIS BY AGENT TYPE
6.76 THAILAND MARKET ANALYSIS BY APPLICATION METHOD
6.77 THAILAND MARKET ANALYSIS BY CROP TYPE
6.78 THAILAND MARKET ANALYSIS BY FUNCTIONALITY
6.79 THAILAND MARKET ANALYSIS BY FORMULATION TYPE
6.80 INDONESIA MARKET ANALYSIS BY AGENT TYPE
6.81 INDONESIA MARKET ANALYSIS BY APPLICATION METHOD
6.82 INDONESIA MARKET ANALYSIS BY CROP TYPE
6.83 INDONESIA MARKET ANALYSIS BY FUNCTIONALITY
6.84 INDONESIA MARKET ANALYSIS BY FORMULATION TYPE
6.85 REST OF APAC MARKET ANALYSIS BY AGENT TYPE
6.86 REST OF APAC MARKET ANALYSIS BY APPLICATION METHOD
6.87 REST OF APAC MARKET ANALYSIS BY CROP TYPE
6.88 REST OF APAC MARKET ANALYSIS BY FUNCTIONALITY
6.89 REST OF APAC MARKET ANALYSIS BY FORMULATION TYPE
6.90 SOUTH AMERICA MARKET ANALYSIS
6.91 BRAZIL MARKET ANALYSIS BY AGENT TYPE
6.92 BRAZIL MARKET ANALYSIS BY APPLICATION METHOD
6.93 BRAZIL MARKET ANALYSIS BY CROP TYPE
6.94 BRAZIL MARKET ANALYSIS BY FUNCTIONALITY
6.95 BRAZIL MARKET ANALYSIS BY FORMULATION TYPE
6.96 MEXICO MARKET ANALYSIS BY AGENT TYPE
6.97 MEXICO MARKET ANALYSIS BY APPLICATION METHOD
6.98 MEXICO MARKET ANALYSIS BY CROP TYPE
6.99 MEXICO MARKET ANALYSIS BY FUNCTIONALITY
6.100 MEXICO MARKET ANALYSIS BY FORMULATION TYPE
6.101 ARGENTINA MARKET ANALYSIS BY AGENT TYPE
6.102 ARGENTINA MARKET ANALYSIS BY APPLICATION METHOD
6.103 ARGENTINA MARKET ANALYSIS BY CROP TYPE
6.104 ARGENTINA MARKET ANALYSIS BY FUNCTIONALITY
6.105 ARGENTINA MARKET ANALYSIS BY FORMULATION TYPE
6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGENT TYPE
6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION METHOD
6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CROP TYPE
6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY FUNCTIONALITY
6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORMULATION TYPE
6.111 MEA MARKET ANALYSIS
6.112 GCC COUNTRIES MARKET ANALYSIS BY AGENT TYPE
6.113 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION METHOD
6.114 GCC COUNTRIES MARKET ANALYSIS BY CROP TYPE
6.115 GCC COUNTRIES MARKET ANALYSIS BY FUNCTIONALITY
6.116 GCC COUNTRIES MARKET ANALYSIS BY FORMULATION TYPE
6.117 SOUTH AFRICA MARKET ANALYSIS BY AGENT TYPE
6.118 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION METHOD
6.119 SOUTH AFRICA MARKET ANALYSIS BY CROP TYPE
6.120 SOUTH AFRICA MARKET ANALYSIS BY FUNCTIONALITY
6.121 SOUTH AFRICA MARKET ANALYSIS BY FORMULATION TYPE
6.122 REST OF MEA MARKET ANALYSIS BY AGENT TYPE
6.123 REST OF MEA MARKET ANALYSIS BY APPLICATION METHOD
6.124 REST OF MEA MARKET ANALYSIS BY CROP TYPE
6.125 REST OF MEA MARKET ANALYSIS BY FUNCTIONALITY
6.126 REST OF MEA MARKET ANALYSIS BY FORMULATION TYPE
6.127 KEY BUYING CRITERIA OF PHARMACEUTICAL
6.128 RESEARCH PROCESS OF MRFR
6.129 DRO ANALYSIS OF PHARMACEUTICAL
6.130 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
6.131 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
6.132 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
6.133 PHARMACEUTICAL, BY AGENT TYPE, 2024 (% SHARE)
6.134 PHARMACEUTICAL, BY AGENT TYPE, 2024 TO 2035 (USD Billion)
6.135 PHARMACEUTICAL, BY APPLICATION METHOD, 2024 (% SHARE)
6.136 PHARMACEUTICAL, BY APPLICATION METHOD, 2024 TO 2035 (USD Billion)
6.137 PHARMACEUTICAL, BY CROP TYPE, 2024 (% SHARE)
6.138 PHARMACEUTICAL, BY CROP TYPE, 2024 TO 2035 (USD Billion)
6.139 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 (% SHARE)
6.140 PHARMACEUTICAL, BY FUNCTIONALITY, 2024 TO 2035 (USD Billion)
6.141 PHARMACEUTICAL, BY FORMULATION TYPE, 2024 (% SHARE)
6.142 PHARMACEUTICAL, BY FORMULATION TYPE, 2024 TO 2035 (USD Billion)
6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.2.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.2.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.2.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.2.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.3.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.3.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.3.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.3.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.4.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.4.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.4.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.4.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.5.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.5.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.5.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.5.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.6.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.6.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.6.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.6.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.7.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.7.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.7.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.7.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.8.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.8.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.8.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.8.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.9.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.9.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.9.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.9.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.10.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.10.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.10.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.10.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.11.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.11.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.11.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.11.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.12.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.12.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.12.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.12.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.13.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.13.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.13.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.13.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.14.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.14.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.14.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.14.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.15.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.15.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.15.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.15.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.16.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.16.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.16.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.16.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.17.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.17.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.17.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.17.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.18.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.18.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.18.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.18.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.19.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.19.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.19.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.19.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.20.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.20.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.20.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.20.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.21.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.21.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.21.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.21.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.22.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.22.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.22.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.22.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.23.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.23.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.23.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.23.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.24.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.24.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.24.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.24.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.25.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.25.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.25.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.25.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.26.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.26.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.26.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.26.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.27.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.27.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.27.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.27.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.28.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.28.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.28.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.28.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.29.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.29.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.29.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.29.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY AGENT TYPE, 2025-2035 (USD Billion)
7.30.2 BY APPLICATION METHOD, 2025-2035 (USD Billion)
7.30.3 BY CROP TYPE, 2025-2035 (USD Billion)
7.30.4 BY FUNCTIONALITY, 2025-2035 (USD Billion)
7.30.5 BY FORMULATION TYPE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Pharmaceutical Market Segmentation

Pharmaceutical By Agent Type (USD Billion, 2025-2035)

Microbial Control Agents
Natural Predators
Bioinsecticides
Biopesticides
Entomopathogenic Nematodes

Pharmaceutical By Application Method (USD Billion, 2025-2035)

Soil Application
Foliar Application
Seed Treatment

Pharmaceutical By Crop Type (USD Billion, 2025-2035)

Field Crops
Horticultural Crops
Ornamental Plants
Fruit and Vegetable Crops

Pharmaceutical By Functionality (USD Billion, 2025-2035)

Pest Control
Disease Control
Weed Control

Pharmaceutical By Formulation Type (USD Billion, 2025-2035)

Liquid Formulations
Granular Formulations
Powder Formulations

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓